We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Notice of Annual General Meeting in Karolinska Development AB (publ) The shareholders of Karolinska Development AB (publ), reg. no. 556707-5048, (“Karolinska Development” or the “Company”) are...
Karolinska Development’s portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBC STOCKHOLM, SWEDEN – March 22, 2024. Karolinska...
Karolinska Development Annual Report 2023 published STOCKHOLM, SWEDEN – March 22, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces publication of its Annual Report 2023...
Karolinska Development’s portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 million STOCKHOLM, SWEDEN, March 14, 2024. Karolinska Development AB (Nasdaq...
Karolinska Development’s portfolio company Biosergen publishes prospectus due to rights issue of units STOCKHOLM, Sweden, March 14 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV...
Karolinska Development’s portfolio company Umecrine Cognition presents preclinical Parkinson’s data on golexanolone at AD/PD STOCKHOLM, SWEDEN – March 6, 2024. Karolinska Development AB (Nasdaq...
Year-end Report - January-December 2023 STOCKHOLM – 16 February 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Year-end Report - January-December 2023. The full...
Karolinska Development’s portfolio company AnaCardio secures SEK 50 million as part of its Series A investment round STOCKHOLM, SWEDEN January 17, 2024. Karolinska Development AB (Nasdaq...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 6.5 | 6.5 | 6.5 | 2359 | 6.5 | DE |
52 | 0 | 0 | 6.5 | 6.5 | 6.5 | 5897 | 6.5 | DE |
156 | 0 | 0 | 6.5 | 6.5 | 6.5 | 8284 | 6.5 | DE |
260 | 0 | 0 | 6.5 | 6.5 | 6.5 | 9221 | 6.5 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions